相关实验视频
Updated: Jul 18, 2025
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.6K
杜皮卢马布可以改善由2型炎症为特征的获得反应性穿孔性原蛋白症
Ben Liu1, Yibei Wu2, Xiaoyan Wu1
1Department of Dermatology, The Eighth Affliated hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.
Frontiers in immunology
|August 28, 2023
概括
杜皮卢马布有效地治疗获得的反应性穿孔性原体病 (ARPC),显著改善患者的得分并减少. 这种疗法对ARPC有希望,ARPC是一种与2型炎症相关的疾病.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 皮肤疾病的发病因子.
背景情况:
- 获得的反应性穿孔性原体病 (ARPC) 带来了不完全理解的病原体的临床挑战.
- ARPC的特点是皮肤部件的皮肤间消除,这通常与全身性疾病有关.
研究的目的:
- 评估dupilumab在治疗ARPC中的疗效和安全性.
- 研究2型炎症相关分子在ARPC病变中的作用.
主要方法:
- 一项回顾性队列研究涉及20名ARPC患者,其中10人接受dupilumab和10人接受常规治疗.
- 在12周评估有效性和安全性;在ARPC,亚托皮炎 (AD) 和健康对照组的皮肤样本上进行的免疫组织化学和免疫光分析.
主要成果:
- 与传统组相比,dupilumab组在调查者全球评估分数 (100%与0%) 和 (90%与8.33%) 中显著改善.
- ARPC病变呈现出增加的CD3+T细胞透,主要是Th2细胞,反映了AD病变.
- 发现IL-4和IL-13在ARPC病变中与GATA3共同局部化,表明2型炎症特征.
结论:
- 杜皮卢马布在治疗ARPC方面显示出显著的疗效和安全性.
- 这项研究支持2型炎症在ARPC病变发生中的作用.
- 杜皮卢马布通过向关键炎症途径,代表了ARPC的潜在治疗选择.
关键词:
在ARPC上,ARPC是ARPC的合作伙伴.IL13 IL13 IL13 IL13 IL13 IL13 IL13 IL13 IL13 IL13 IL13IL4 IL4 IL4 IL4 IL4 IL4 IL4 IL4 IL4 IL4 IL4Th2 Th2 的意思是什么?双重复制的马布.更多相关视频
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
8.4K
11:49Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
16.1K
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
285
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
285
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
213
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213
01:27Allergic Drug Reactions
875
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
875
01:30Hypersensitivities
735
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
735
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195